Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial.
- DOI
- 10.1016/j.jad.2026.122265
- Published
- 2026 Nov 15
- Container
- Journal of affective disorders
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jad.2026.122265,
title = {Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial.},
author = {Massetti S and Smith-Apeldoorn SY and Veraart JKE and Kamphuis J and Muller Kobold A and Tzavara ET and Meerlo P and Schoevers RA and van Dalfsen JH},
year = {2026},
journal = {Journal of affective disorders},
doi = {10.1016/j.jad.2026.122265},
url = {https://doi.org/10.1016/j.jad.2026.122265}
}RIS
TY - JOUR TI - Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial. AU - Massetti S AU - Smith-Apeldoorn SY AU - Veraart JKE AU - Kamphuis J AU - Muller Kobold A AU - Tzavara ET AU - Meerlo P AU - Schoevers RA AU - van Dalfsen JH PY - 2026 JO - Journal of affective disorders DO - 10.1016/j.jad.2026.122265 UR - https://doi.org/10.1016/j.jad.2026.122265 ER -
APA
S, M., SY, S., JKE, V., J, K., A, M. K., ET, T., P, M., RA, S., & JH, V. D. (2026). Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial.. Journal of affective disorders. https://doi.org/10.1016/j.jad.2026.122265
Source records
- pubmed · retrieved 2026-09-25T00:20:47.098Z